Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by IVERIC bio, Inc.

< Previous 1 2 Next >
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Reports Second Quarter 2022 Operational Highlights and Financial Results
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Announces Agreement for Up to $250 Million in Non-Dilutive Debt Financing with Hercules Capital and Silicon Valley Bank
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio to Report Second Quarter 2022 Financial Results and Host Conference Call on Tuesday, July 26, 2022
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Announces Post-Hoc Analysis from GATHER1 Clinical Trial of Zimura® at American Society of Retina Specialists Meeting
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio and DelSiTech Enter Exclusive Agreement for Development of Sustained Release Zimura®
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Announces Presentation of Post-Hoc Analysis at Macula Society from GATHER1 Clinical Trial of Zimura® in Patients with Geographic Atrophy
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio to Present at the UBS Global Healthcare Conference 2022
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio to Participate in the H.C. Wainwright Global Investment Conference
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Reports First Quarter 2022 Operational Highlights and Financial Results
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Announces Presentation of Post-Hoc Analysis from GATHER1 Clinical Trial of Zimura® in Patients with Geographic Atrophy
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC Bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio to Report First Quarter 2022 Financial Results and Host Conference Call on Wednesday, May 4, 2022
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio to Participate in the B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Reports Fourth Quarter and Full Year 2021 Operational Highlights and Financial Results
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio to Report Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on Thursday, February 24, 2022
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Announces Foveal Anatomy Post-Hoc Analysis from GATHER1 Clinical Trial of Zimura® in Patients with Geographic Atrophy
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Announces New Post-Hoc Analyses of Zimura® from GATHER1 Clinical Trial to Be Presented at Angiogenesis, Exudation, and Degeneration 2022
From IVERIC Bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio to Present at the H.C. Wainwright BioConnect Virtual Conference
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Appoints Tony Gibney as Executive Vice President and Chief Business and Strategy Officer
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio to Participate in the Stifel 2021 Virtual Healthcare Conference
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Reports Third Quarter 2021 Operational Highlights and Financial Results
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio to Participate in the Credit Suisse 30th Annual Virtual Healthcare Conference
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
Iveric Bio to Report Third Quarter 2021 Financial Results and Host Conference Call on Tuesday, November 9, 2021
From IVERIC bio, Inc.
Via Business Wire
Tickers ISEE
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.